Concert Pharmaceuticals, Inc.
Deuterated idebenone

Last updated:

Abstract:

The present invention in one embodiment provides a method of treating Leber's hereditary optic neuropathy, comprising administering to a subject in need of such treatment a compound of Formula I: ##STR00001## or a pharmaceutically acceptable salt thereof, wherein the variables shown in Formula I are as defined in the specification.

Status:
Grant
Type:

Utility

Filling date:

16 May 2019

Issue date:

24 Nov 2020